PolyPid Correlations

PYPD Stock  USD 4.46  0.09  2.06%   
The current 90-days correlation between PolyPid and Annovis Bio is 0.21 (i.e., Modest diversification). The correlation of PolyPid is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

PolyPid Correlation With Market

Modest diversification

The correlation between PolyPid and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

Moving together with PolyPid Stock

  0.73VERA Vera TherapeuticsPairCorr
  0.71DRUG Bright Minds BiosciencesPairCorr
  0.77DRTS Alpha Tau MedicalPairCorr
  0.73DSGN Design TherapeuticsPairCorr
  0.840P6S Bayer AG NAPairCorr
  0.84DVAX Dynavax TechnologiesPairCorr
  0.77VNDA Vanda PharmaceuticalsPairCorr
  0.65VRDN Viridian TherapeuticsPairCorr
  0.79VRTX Vertex PharmaceuticalsPairCorr

Moving against PolyPid Stock

  0.81DRMA Dermata TherapeuticsPairCorr
  0.68RAC Race OncologyPairCorr
  0.64VANI Vivani MedicalPairCorr
  0.64AVH Avita MedicalPairCorr
  0.45CMB Cambium BioPairCorr
  0.77PYC Physiomics PlcPairCorr
  0.71DWTX Dogwood TherapeuticsPairCorr
  0.67DTIL Precision BioSciencesPairCorr
  0.6VIVS VivoSim Labs Symbol ChangePairCorr
  0.59VINC Vincerx Pharma CommonPairCorr
  0.51DYAI Dyadic InternationalPairCorr
  0.82BSFA BSF Enterprise PlcPairCorr
  0.79EDIT Editas MedicinePairCorr
  0.75MRVL Marvel Biosciences CorpPairCorr
  0.75EDSA Edesa BiotechPairCorr
  0.74VTGN VistaGen TherapeuticsPairCorr
  0.67VRAX Virax Biolabs GroupPairCorr
  0.62CDTTW Conduit PharmaceuticalsPairCorr
  0.41VSTM VerastemPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BTAIVERU
BTAIEVAX
BTAICELU
VERUEVAX
CELURVPH
VERUCELU
  

High negative correlations

MAIABCAB
VERUANVS
PDSBBCAB
MAIARVPH
EVAXANVS
MAIACELU

Risk-Adjusted Indicators

There is a big difference between PolyPid Stock performing well and PolyPid Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PolyPid's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANVS  5.40  1.02  0.16  2.44  5.21 
 14.79 
 41.06 
RVPH  6.55 (0.37) 0.00 (0.16) 0.00 
 10.71 
 75.31 
BCAB  6.97 (0.65) 0.00  0.32  0.00 
 15.28 
 54.11 
EVAX  5.62 (0.49) 0.00 (1.45) 0.00 
 9.43 
 69.70 
CELU  3.65 (0.85) 0.00 (0.47) 0.00 
 9.01 
 26.97 
MAIA  5.12  0.24  0.06  0.19  5.80 
 9.76 
 35.91 
VERU  3.42 (0.75) 0.00 (0.26) 0.00 
 6.17 
 21.79 
ATNM  3.28 (0.25) 0.00 (0.14) 0.00 
 6.29 
 25.17 
BTAI  4.15 (0.42) 0.00 (1.64) 0.00 
 8.90 
 21.49 
PDSB  4.08 (0.08) 0.01  0.06  4.59 
 8.60 
 27.78 

PolyPid Corporate Management

Ori WarshavskyChief USProfile
MD MBAChief OfficerProfile
Dikla AkselbradChief OfficerProfile
Malka ReichartScientific DirectorProfile
Rivi LevariVice ResourceProfile
Orna BlumLegal CounselProfile
JeanMarc PharmDChief OfficerProfile